Author:
Gallardo A.,Abraham G. A.,Elvira C.,Vázquez B.,San Román J.
Reference42 articles.
1. Hoffman, A.S. (1998) A commentary on the advantages and limitations of synthetic polymer-biomolecule conjugates, in T. Okano (ed.), Biorelated polymer and gels, Academic Press, San Diego, pp. 231–248.
2. Ringsdorf, H. (1975) Structure and properties of pharmacologically active polymers, J. Polym. Sci Polym.Symp. 51, 35–53.
3. Duncan, R. (1992) Drug-polymer conjugates: potential for improved chemotherapy, Anti-Cancer Drugs 3, 175–210.
4. Putnam, D. and Kopecek J. (1995) Polymer conjugates with anticancer activity, Adv. in Polym. Sci. 122, 55–123.
5. Maeda, H. (1991) SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy, Adv. Drug Delivery Review 6, 181–202.